Final answer:
Kara Smith, at 34 years old and pregnant for the first time, is being induced at 39 weeks due to suspected macrosomia and GDM A2, which requires medical management. Her non-compliance with treatment raises risks for complications for both her and the fetus. Managing GDM involves strict adherence to lifestyle changes, blood glucose monitoring, and possibly medication.
Step-by-step explanation:
Kara Smith is a 34-year-old primigravida (G1P0) who is being induced at 39 weeks due to suspected macrosomia and Gestational Diabetes Mellitus type A2 (GDM A2). Macrosomia refers to a condition where a fetus is significantly larger than average for its gestational age, often defined as weighing more than 4000 to 4500 grams at birth. Gestational Diabetes is a form of diabetes that develops during pregnancy and can lead to complications such as large for gestational age (LGA) infants. The A2 classification indicates that the gestational diabetes is significant enough to require insulin or oral medication for blood sugar control.
In this case, Kara Smith's non-compliance in managing her gestational diabetes raises concerns for both her health and the health of the fetus. Non-compliance may result in poorly controlled blood sugar levels, which in turn increases the risk of complications such as preterm birth, cesarean delivery, and neonatal hypoglycemia.
Management of GDM includes lifestyle modifications, monitoring blood glucose levels, and possibly medication. It is crucial for patients to adhere to their treatment plan to mitigate risks associated with the condition.